Stock comparison
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
West Pharmaceutical Services
WST$22.35BHealthcare Market cap, Sector
Overall winner
United Therapeutics
UTHR 52 WST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
UTHR5wins
2winsWST
71B
D58
76B
A88
76B
D47
62C
F24
46D
C60
64C
C60
64C
D54
Side-by-side metrics
| Metric | UTHR | WST |
|---|---|---|
| Market cap | Winner: $24.13B | $22.35B |
| P/E (TTM) | Winner: 19.2x | 39.8x |
| EV/EBIT | Winner: 15.2x | 34.0x |
| ROIC (TTM) | Winner: 18.81% | 15.24% |
| Gross margin | Winner: 86.58% | 36.24% |
| Net margin | Winner: 40.61% | 16.85% |
| Revenue CAGR 5y | Winner: 17.22% | 2.08% |
| EPS CAGR 5y | Winner: 29.84% | -6.4% |
| Debt / Equity | Winner: - | 0.1x |
| Dividend yield | 0.0% | 0.29% Winner |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- EPS CAGR 5y29.84%vs -6.4%+121%
- Debt / Equity-vs 0.1x+100%
- Revenue CAGR 5y17.22%vs 2.08%+88%
- Net margin40.61%vs 16.85%+59%
WST leads on
- Dividend yield0.29%vs 0.0%+100%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.